These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6832847)

  • 1. Prediction of malignant melanoma recurrence by serum N-acetylneuraminic acid.
    Silver HK; Murray RN; Worth AJ; Salinas FA; Spinelli JJ
    Int J Cancer; 1983 Jan; 31(1):39-43. PubMed ID: 6832847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear DNA, serum sialic acid and measured depth in malignant melanoma for predicting disease recurrence and survival.
    Silver HK; Karim KA; Le Riche J; de Jong G; Spinelli J; Worth A; McLean DI; Gallagher R
    Int J Cancer; 1989 Jul; 44(1):31-4. PubMed ID: 2744894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sialic acid elevations in malignant melanoma patients.
    Silver HK; Rangel DM; Morton DL
    Cancer; 1978 Apr; 41(4):1497-9. PubMed ID: 639006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of N-acetylneuraminic acid (NANA) in the serum of patients with gynecologic cancers].
    Schrempel A; Kürschner M
    Zentralbl Gynakol; 1985; 107(3):175-8. PubMed ID: 3984572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of histological regression as a prognostic factor in cutaneous melanoma patients.
    Tas F; Erturk K
    Melanoma Res; 2016 Oct; 26(5):492-6. PubMed ID: 27380112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant melanoma: depth of invasion and histologic typing].
    Hermanek P; Hornstein OP; Tonak J; Weidner F
    Beitr Pathol; 1976 May; 157(3):269-82. PubMed ID: 1275868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma in the elderly.
    Cohen HJ; Cox E; Manton K; Woodbury M
    J Clin Oncol; 1987 Jan; 5(1):100-6. PubMed ID: 3806154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of galectin-3 in primary cutaneous melanoma.
    Buljan M; Šitum M; Tomas D; Milošević M; Krušlin B
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1174-81. PubMed ID: 21175876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of putative tumor markers for malignant melanoma.
    Reintgen DS; Cruse CW; Wells KE; Saba HI; Fabri PJ
    Ann Plast Surg; 1992 Jan; 28(1):55-9. PubMed ID: 1642407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
    Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum sialic acid bound to lipoproteins. Its contribution to the diagnosis and follow-up of melanoma].
    Sánchez Conejo-Mir J; Sotillo Gago I; Camacho F; Iglesias Huertas R
    Med Cutan Ibero Lat Am; 1990; 18(4):219-23. PubMed ID: 2077306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases.
    Pizzichetta MA; Massi D; Mandalà M; Queirolo P; Stanganelli I; De Giorgi V; Ghigliotti G; Cavicchini S; Quaglino P; Corradin MT; Rubegni P; Alaibac M; Astorino S; Ayala F; Magi S; Mazzoni L; Manganoni MA; Talamini R; Serraino D; Palmieri G;
    J Transl Med; 2017 Nov; 15(1):227. PubMed ID: 29115977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low- and high-risk malignant melanoma--II. Multivariate analyses for a prognostic classification.
    Schmoeckel C; Bockelbrink A; Bockelbrink H; Braun-Falco O
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):237-43. PubMed ID: 6681769
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of N-acetylneuraminic acid in severe malnutrition.
    Hibbert JM; Jackson AA; Grantham-McGregor SM
    Br J Nutr; 1985 Jan; 53(1):11-6. PubMed ID: 3933545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in thin cutaneous malignant melanoma.
    Månsson-Brahme E; Carstensen J; Erhardt K; Lagerlöf B; Ringborg U; Rutqvist LE
    Cancer; 1994 May; 73(9):2324-32. PubMed ID: 8168037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the prognostic importance of white depressed areas in the primary lesion of superficial spreading melanoma.
    McLean DI; Lew RA; Sober AJ; Mihm MC; Fitzpatrick TB
    Cancer; 1979 Jan; 43(1):157-61. PubMed ID: 761159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study.
    Cohn-Cedermark G; Månsson-Brahme E; Rutqvist LE; Larsson O; Singnomklao T; Ringborg U
    Cancer; 1997 Oct; 80(8):1418-25. PubMed ID: 9338465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysis.
    Stanelle EJ; Busam KJ; Rich BS; Christison-Lagay ER; Dunkel IJ; Marghoob AA; Halpern A; Coit DG; La Quaglia MP
    J Pediatr Surg; 2015 Jun; 50(6):1019-23. PubMed ID: 25819019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.